SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001461993-19-000030
Filing Date
2019-06-12
Accepted
2019-06-12 13:36:48
Documents
1
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156036099405068.html 4  
1 FORM 4 wf-form4_156036099405068.xml 4 3973
  Complete submission text file 0001461993-19-000030.txt   5512
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 300 TRI STATE INTERNATIONAL SUITE 272 LINCOLNSHIRE IL 60069
Business Address
ZACCARDELLI DAVID (Reporting) CIK: 0001627642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19893329